Cooley Advises Special Committee of Checkpoint on Acquisition by Sun Pharma
March 12, 2025
March 12, 2025
PALO ALTO, California, March 12 -- Cooley, a law firm, issued the following news release:
* * *
Cooley Advises Special Committee of Checkpoint on Acquisition by Sun Pharma
New York - March 9, 2025 - Cooley advised the independent special committee of Checkpoint Therapeutics' (Nasdaq: CKPT) board of directors in connection with Checkpoint's definitive agreement to be acquired by Sun Pharmaceutical Industries (NSE: SUNPHARMA) for an upfront cash pay . . .
* * *
Cooley Advises Special Committee of Checkpoint on Acquisition by Sun Pharma
New York - March 9, 2025 - Cooley advised the independent special committee of Checkpoint Therapeutics' (Nasdaq: CKPT) board of directors in connection with Checkpoint's definitive agreement to be acquired by Sun Pharmaceutical Industries (NSE: SUNPHARMA) for an upfront cash pay . . .